The methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and cancer risk: The Croatian case-control study

Clinical Biochemistry

Volumn 40, Issue 13-14, 2007, Pages 981-985

  Reljic, Ante ^a   Simundic, Ana Maria ^a   Topic, Elizabeta ^a   Nikolac, Nora ^a   Justinic, Danijel ^a   Stefanovic, Mario ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Breast cancer; Genetic polymorphism; Genetic predisposition to disease; Head and neck cancer; MTHFR; Prostate cancer

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROATIA; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEAD AND NECK CANCER; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLATION; PRIORITY JOURNAL; PROSTATE CANCER; SEX RATIO; STATISTICAL SIGNIFICANCE;

AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CROATIA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 34548127241     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2007.05.005     Document Type: Article

References (38)

1. Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility. J. Clin. Oncol. 14 5 (1996) 1730-1736 (discussion 1737-40)
2. Choi S.W., and Mason J.B. Folate and carcinogenesis: an integrated scheme. J. Nutr. 130 2 (2000) 129-132
3. Choi S.W., and Mason J.B. Folate status: effects on pathways of colorectal carcinogenesis. J. Nutr. 132 8 Suppl. (2002) 2413S-2418S
4. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat. Gen. 10 (1995) 111-113
5. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, et al. Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast Cancer Res Treat 2006 [in press].
6. Karagas M.R., Park S., Nelson H.H., Andrew A.S., Mott L., Schned A., et al. Methylenetetrahydrofolate reductase (MTHFR) variants and bladder cancer: a population-based case-control study. Int. J. Hyg. Environ. Health 208 5 (2005) 321-327
7. Van Guelpen B.R., Wiren S.M., Bergh A.R., Hallmans G., Stattin P.E., and Hultdin J. Polymorphisms of methylenetetrahydrofolate reductase and the risk of prostate cancer: a nested case-control study. Eur. J. Cancer Prev. 15 1 (2006) 46-50
8. Hubner R.A., and Houlston R.S. MTHFR C677T and colorectal cancer risk: a meta-analysis of 25 populations. Int. J. Cancer 120 5 (2007) 1027-1035
9. Eble J.N., Sauter G., Epstein J.I., and Sesterhenn I.A. WHO classification of tumours: pathology and genetics of tumours of the urinary system and male genital organs (2004), IARC Press, Lyon
10. Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. WHO classification of tumours: pathology and genetics of tumours of the breast and female genital organs (2003), IARC Press, Lyon
11. Barnes L., Eveson J., Reichart P., and Sidransky D. WHO classification of tumours: pathology and genetics of tumours of the head and neck (2005), IARC Press, Lyon
12. Skibola C.F., Smith M.T., Kane E., Roman E., Rollinson S., Cartwright R.A., and Morgan G. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc. Natl. Acad. Sci. U. S. A. 96 22 (1999) 12810-12815
13. Dumitrescu R.G., and Cotarla I. Understanding breast cancer risk-Where do we stand in 2005?. J. Cell. Mol. Med. 9 1 (2005) 208-221
14. Olshan A.F., Weissler M.C., Watson M.A., and Bell D.A. GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol., Biomarkers Prev. 9 2 (2000) 185-191
15. Tripathy C.B., and Roy N. Meta-analysis of glutathione S-transferase M1 genotype and risk toward head and neck cancer. Head Neck 28 3 (2006) 217-224
16. Boccia S., Cadoni G., La Torre G., Arzani D., Volante M., Cattel C., et al. A case-control study investigating the role of sulfotransferase 1A1 polymorphism in head and neck cancer. J. Cancer Res. Clin. Oncol. 132 7 (2006) 466-472
17. Larsson S.C., Giovannucci E., and Wolk A. Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 131 4 (2006) 1271-1283
18. Kureshi N., Ghaffar S., Siddiqui S., Salahuddin I., and Frossard P.M. Head and neck cancer susceptibility: a genetic marker in the methylenetetrahydrofolate reductase gene. Orl. J. Oto-Rhino-Laryngol. Relat. Spec. 66 5 (2004) 241-245
19. Zhang J., Zotz R.B., Li Y., Wang R., Kiel S., and Schulz W.A. Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. J. Cancer Res. Clin. Oncol. 130 10 (2004) 574-580
20. Neumann A.S., Lyons H.J., Shen H., Liu Z., Shi Q., Sturgis E.M., et al. Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int. J. Cancer 115 (2005) 131-136
21. Kraunz K.S., Hsiung D., Mc Clean M.D., Liu M., Osanyingbemi J., Nelson H.H., et al. Dietary folate is associated with p16(INK4A) methylation in head and neck squamous cell carcinoma. Int. J. Cancer 119 (2006) 1553-1557
22. Bailey L.B. Folate, methyl-related nutrients, alcohol, and the MTHFR 677C→T polymorphism affect cancer risk: intake recommendations. J. Nutr. 133 11 Suppl. 1 (2003) 3748S-3753S
23. Kane M.A. The role of folates in squamous cell carcinoma of the head and neck. Cancer Detect. Prev. 29 1 (2005) 46-53
24. Schaid D.J. Investigators of the International Consortium for Prostate Cancer Genetics. Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum. Genet. 120 4 (2006) 471-485
25. Shand R.L., and Gelmann E.P. Molecular biology of prostate-cancer pathogenesis. Curr. Opin. Urol. 16 3 (2006) 123-131
26. Cicek M.S., Nock N.L., Li L., Conti D.V., Casey G., and Witte J.S. Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness. Cancer Epidemiol., Biomarkers Prev. 13 8 (2004) 1331-1336
27. Kimura F., Franke K.H., Steinhoff C., Golka K., Roemer H.C., Anastasiadis A.G., et al. Methyl group metabolism gene polymorphisms and susceptibility to prostatic carcinoma. Prostate 1 45 (3) (2001) 225-231
28. Singal R., Ferdinand L., Das P.M., Reis I.M., and Schlesselman J.J. Polymorphisms in the methylenetetrahydrofolate reductase gene and prostate cancer risk. Int. J. Oncol. 25 5 (2004) 1465-1471
29. Heijmans B.T., Boer J.M., Suchiman H.E., Cornelisse C.J., Westendorp R.G., Kromhout D., et al. A common variant of the methylenetetrahydrofolate reductase gene (1p36) is associated with an increased risk of cancer. Cancer Res. 15 63 (6) (2003) 1249-1253
30. Justenhoven C., Hamann U., Pierl C.B., Rabstein S., Pesch B., Harth V., et al. One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany. Cancer Epidemiol., Biomarkers Prev. 14 12 (2005) 3015-3018
31. Le Marchand L., Haiman C.A., Wilkens L.R., Kolonel L.N., and Henderson B.E. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol., Biomarkers Prev. 13 (2004) 2071-2077
32. Sharp L., Little J., Schofield A.C., et al. Folate and breast cancer: the role of polymorphisms in methylenetetrahydrofolate reductase (MTHFR). Cancer Lett. 181 (2002) 65-71
33. Semenza J.C., Delfino R.J., Ziogas A., and Anton-Culver H. Breast cancer risk and methylenetetrahydrofolate reductase polymorphism. Breast Cancer Res. Treat. 77 (2003) 217-223
34. Kalemi T.G., Lambropoulos A.F., Gueorguiev M., et al. The association of p53 mutations and p53 codon 72, Her 2 codon 655 and MTHFR C677T polymorphisms with breast cancer in Northern Greece. Cancer Lett. 222 (2005) 57-65
35. Ergul E., Sazci A., Utkan Z., and Canturk N.Z. Polymorphisms in the MTHFR gene are associated with breast cancer. Tumor Biol. 24 6 (2003) 286-290
36. Deligezer U., Akisik E.E., and Dalay N. Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population. In Vivo 19 5 (2005) 889-893
37. Gershoni-Baruch R., Dagan E., Israeli D., et al. Association of the C677T polymorphism in the MTHFR gene with breast and/or ovarian cancer risk in Jewish women. Eur. J. Cancer 36 (2000) 2313-2316
38. Zintzaras E. Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clin. Genet. 69 (2006) 326-327